Amicus Therapeutics
FOLD
FOLD
135 hedge funds and large institutions have $780M invested in Amicus Therapeutics in 2016 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 55 increasing their positions, 34 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 136 → 135 (-1)
28% less capital invested
Capital invested by funds: $1.08B → $780M (-$302M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
135
Holding in Top 10
4
Calls
$16.4M
Puts
$6.15M
Top Buyers
| 1 | +$15.8M | |
| 2 | +$14.9M | |
| 3 | +$10.8M | |
| 4 |
Jennison Associates
New York
|
+$6.82M |
| 5 |
JPMorgan Chase & Co
New York
|
+$4.81M |
Top Sellers
| 1 | -$12M | |
| 2 | -$10M | |
| 3 | -$9.4M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$7.27M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.45M |